One study found that MRI features, such as the proportion of enhancing and non-enhancing tumors, the amount of restricted diffusion, and the proportion of edema, significantly varied between gliomas with methylated MGMT versus unmethylated MGMT. This evidence concerns the gene MGMT and central nervous system cancer.